Abstract
Allergic rhinitis (AR) is a disease with high prevalence. In AR, exposure to airborne allergens elicits an allergic response which involves epithelial accumulation of effector cells — e.g. mast cells and basophils — and subsequent inflammation. During the early response in AR, histamine has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the histamine H1 receptor. Therefore, anti-histamines have a role to play in the management of AR. However, the available antihistamines have certain well-known side effects like sedation and potential pro-arrythmic effects owing to their interactions with other drugs, as well as having poor or no effect on platelet activating factor (PAF) which also plays an important role in AR. This article is a qualitative systematic literature review on the pharmacological profile of rupatadine in order to evaluate its safety and efficacy in AR as compared to other anti-histamines. Rupatadine is a once-daily non-sedative, selective, long-acting H1 anti-histamine with antagonistic PAF effects through its interaction with specific receptors. Rupatadine significantly improves nasal symptoms in patients with AR. It has a good safety profile and is devoid of arrythmogenic effects. These properties make rupatadine a suitable first line anti-histamine for the treatment of AR.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
None declared.
Rights and permissions
About this article
Cite this article
Katiyar, S., Prakash, S. Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis. Prim Care Respir J 18, 57–68 (2009). https://doi.org/10.3132/pcrj.2008.00043
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3132/pcrj.2008.00043
This article is cited by
-
Rupatadin — Wirksamkeit und Sicherheit eines nichtsedierenden Antihistaminikums mit PAF-antagonisierender Wirkung
Allergo Journal (2014)
-
Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects
Allergo Journal International (2014)